Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2022-04-11 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2022. It is issued by the Registrar and Share Transfer Agent certifying details of securities dematerialized/rematerialized during the quarter. The document is addressed to stock exchanges and is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a regulatory compliance filing. The document length is 4439 characters, which is relatively short and focused on certification. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate under SEBI regulations.
2022-04-11 English
Price movement
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 176 characters, which is extremely short and contains no report or announcement details. Given the lack of content, this cannot be classified as a full report or detailed announcement. It is most consistent with a Regulatory Filing (RNS) as a fallback category for documents that do not fit any other specific filing type.
2022-04-08 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter from Neuland Laboratories Limited addressed to BSE Limited, providing a clarification on the significant price movement of the company's security. It references a BSE email requesting clarification and reiterates the company's compliance with disclosure regulations under SEBI Listing Obligations. The content is a regulatory communication responding to a stock exchange query about share price movement, without any financial data, report, or detailed analysis. The document length is short (1850 characters), and it is clearly a regulatory filing or disclosure rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2022-04-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a tabular disclosure under Regulation 31(4) listing promoters and promoter group members of Neuland Laboratories Limited for the financial year ending 31-Mar-2022. This type of disclosure corresponds to notifications about major shareholding or promoter holdings as per regulatory requirements. The document length is short (1346 characters) and contains no financial statements or management commentary. It is not an annual report, earnings release, or any other detailed financial or governance report. The content fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes or status of significant share ownership levels.
2022-04-06 English
Closure of trading window
Regulatory Filings Classification · 90% confidence The document text is extremely short (118 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) by default, as it does not meet criteria for any other category.
2022-03-30 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by a shareholder. It includes a notice published in newspapers about the lost share certificates and instructions for claimants to apply for duplicate certificates. The content is a regulatory announcement informing the public and investors about the lost certificates and the company's process for issuing confirmation letters in lieu of duplicates. There are no financial statements, management discussions, or detailed financial data present. The document is not a report but a regulatory notification related to share certificates. Therefore, it fits best under Regulatory Filings (RNS).
2022-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.